Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
Vale SA
VALE
KB Home
KBH
Apple
AAPL
US Stock MarketDetailed Quotes
AUPH Aurinia Pharmaceuticals
- 7.790
- -0.180-2.26%
Close Feb 14 16:00 ET
- 7.790
- 0.0000.00%
Post 20:01 ET
1.12BMarket Cap-51.93P/E (TTM)
8.120High7.770Low1.01MVolume8.000Open7.970Pre Close7.91MTurnover0.76%Turnover RatioLossP/E (Static)143.18MShares10.67052wk High2.87P/B1.03BFloat Cap4.71052wk Low--Dividend TTM131.70MShs Float33.972Historical High--Div YieldTTM4.39%Amplitude1.000Historical Low7.859Avg Price1Lot Size
About Aurinia Pharmaceuticals Company
Aurinia Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Victoria, Canada.
Company Profile
SymbolAUPH
Company NameAurinia Pharmaceuticals
Listing DateFeb 25, 2000
Founded1993
CEOMr. Peter S. Greenleaf
MarketNASDAQ
Employees300
Fiscal Year Ends12-31
Address14315 – 118 Avenue,Suite 140
CityEdmonton
ProvinceAlberta
CountryCanada
Zip CodeT5L 4S6
Phone1-250-744-2487
Websitehttp://www.auriniapharma.com
Company Executives
- Name
- Position
- Salary
- Peter S. Greenleaf
- President, Chief Executive Officer and Director
- 10.57M
- Stephen P. Robertson
- Executive Vice President, General Counsel, Corporate Secretary and Chief Compliance Officer
- 3.60M
- Joseph M. Miller
- Chief Financial Officer and Principal Accounting Officer
- 3.98M
- Matthew Donley
- Executive Vice President, Operations and Strategy
- 4.56M
- Kevin C. Tang
- Director
- --
- Craig A. Johnson
- Director
- --
- Dr. David R.W. Jayne, F.R.C.P.,M.D.
- Independent Director
- 249.92K
- Jill D. Leversage
- Independent Director
- 267.28K
- Jeffrey Allen Bailey
- Independent Director
- 361.51K
- Dr. Karen L. Smith, L.L.M.,M.B.A.,M.D.,PhD
- Independent Director
- 359.41K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.